EW vs TEM · P/E 47, rev $1.39B vs rev $693.4M
Edwards Lifesciences Corp (EW) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TEM revenue for 2024-12-31 was $693.4M. Net income was -$705.8M. Revenue was up 30.4% from 2023-12-31 to 2024-12-31. TEM currently screens at market cap $8.76B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TEM currently screens at market cap $8.76B.
Not investment advice. Open the EW and TEM stock pages for the full models.
Not investment advice.